Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

TeraWulf was up 4.6%, extending its rally from Friday as Alphabet’s Google raised its stake in the company. Google will ...

UnitedHealth Group, the worst-performing stock in the Dow Jones Industrial Average so far this year, got a major boost last ...

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

On Friday, high-profile investors Michael Burry and Warren Buffett took positions in UnitedHealth Group Inc. (NYSE:UNH).

Buffett's $1.57B bet on UNH sparks a 12% surge, lifting peers despite sector headwinds and recent struggles at the insurer.

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...

A cyberattack at U.S. insurance firm Allianz Life in late July compromised the personal data of 1.1 million customers, ...

It has been a rough year for healthcare stocks on the S&P 500, but Warren Buffett’s move into UnitedHealth Group Inc. could ...

Columbia Threadneedle Investments reports strong Q2 gains for its Disciplined Value Fund, driven by smart stock selection.